Search for: "RANBAXY INC" Results 21 - 40 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2007, 5:13 pm
Ranbaxy Inc. et al.3:07-cv-03755; filed August 9, 2007 in the District of Court... [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
30 Sep 2013, 8:12 am by Gene Quinn
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
16 Jul 2010, 7:14 am by The Docket Navigator
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]
23 Oct 2013, 4:17 am by Ben Vernia
On October 23, the long-term care pharmacy giant Omnicare, Inc., filed an 8-K statement with the SEC disclosing that it had reached an agreement in principle to settle allegations of kickbacks raised by a qui tam relator in the Northern District of Ohio, for $120 million. [read post]
3 Mar 2012, 9:45 am by Lawrence B. Ebert
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
13 Sep 2013, 7:43 am
The largest settlement this year involved Ranbaxy, Inc., based in Princeton New Jersey. [read post]
12 Jul 2013, 11:00 am
More Than $34 Million to Resolve False Claims Act Allegations Related to Kyphoplasty, Justice.gov, July 2, 2013 Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations of Defrauding Medicare, Justice.gov, May 22, 2008 More Blog Posts:Nursing Home to Pay $2.7M for Medicaid Fraud Claims Brought to Light By Whistleblower, Boston Injury Lawyer Blog, March 23, 2013 Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and… [read post]
24 May 2021, 7:34 am by Deb Givens
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]